Dihydrotachysterol
From Wikipedia, the free encyclopedia
| Image:Dihydrotachysterol.png | |
|
Dihydrotachysterol
|
|
| Systematic (IUPAC) name | |
| 3-[2-[7a-methyl-1- (1,4,5-trimethylhex-2-enyl)- 1,2,3,3a,5,6,7,7a- octahydroinden-4-ylidene] ethylidene]- 4-methyl-cyclohexan-1-ol | |
| Identifiers | |
| CAS number | 67-96-9 |
| ATC code | A11CC02 |
| PubChem | 5281010 |
| DrugBank | APRD00143 |
| Chemical data | |
| Formula | C28H46O |
| Mol. weight | 398.664 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | >99% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Dihydrotachysterol is a type of Vitamin D (specifically, "D4") used as a medication.
 |
This medical article is a stub. You can help Wikipedia by expanding it. |
